CompletedInterventionalPhase 2Phase 3Updated May 30, 2011
Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension | NCT00332072 | Trialant
CompletedInterventionalPhase 3Updated May 30, 2011
Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension
ClinicalTrials.gov ID
NCT00332072
Lead Sponsor
AllerganINDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Phase 3
Enrollment
541Actual
Last Update Posted
May 30, 2011Estimated
Start Date
Aug 2001
Primary Completion Date
Aug 2003Actual
Completion Date
Aug 2003Actual
Brief Summary
The purpose of this study is to assess the safety and efficacy of Bimatoprost/Timolol Fixed Combination in the treatment of glaucoma or ocular hypertension
Ocular Hypertension
bimatoprost/timolol fixed combination
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Clinical diagnosis of ocular hypertension or chronic glaucoma in both eyes
Patient needs IOP-lowering drug in both eyes
Exclusion Criteria:
Uncontrolled medical condition
Contraindication to beta-adrenoceptor antagonist therapy